AI Governance: Plans in Place?
Implementation of AI governance is imperative for excellent patient care.
Read moreACR Data Science Institute’s AI Central has been updated with three new Transparent-AI products and three new products to the directory.
Three new products were added to our Transparent-AI program, which is designed to increase transparency in imaging AI and help end users have better informed discussions and selection criteria when making decisions about which algorithm might be most appropriate for their local target population.
Perspectum Diagnostics Ltd. joined the Transparent-AI program with their products MRCP+, Hepatica, and LiverMultiScan.
Transparent-AI consists of voluntarily provided data elements solicited from participating imaging AI manufacturers who currently have an FDA-cleared product in the U.S. market. Manufacturers who participate in this program will receive the Transparent-AI badge on their product listing.
Our AI Central directory has also been updated with three new products. This information is pulled directly from FDA 510K documents and updated by ACR staff. With this latest update, we see newly cleared FDA products designed for pediatric x-rays, chest CTs and prostate MR images.
New products include:
EFAI Bonesuite XR Bone Age Pro Assessment System (BAP-XR-100)
Cardiac CT Function Software Application
AI Governance: Plans in Place?
Implementation of AI governance is imperative for excellent patient care.
Read moreState Legislators Introduce AI Bills
The American College of Radiology® (ACR®) is tracking 20 bills across 12 states addressing artificial intelligence (AI) and more bills are expected to be introduced.
Read moreNew HHS Strategic Plan For Artificial Intelligence Echoes ACR Recommendations
The U.S. Department of Health and Human Services (HHS) released a nonbinding roadmap to signal its near- and long-term priorities for artificial intelligence (AI) in healthcare. The plan prioritizes four overarching areas: AI innovation and adoption; trustworthiness and responsible use; democratization and equitable access; and workforce and organizational culture. It echoes various AI policy recommendations of the American College of Radiology® (ACR®) to the federal government over the past decade, and discusses radiology’s leadership in the current healthcare AI market.
Read more